S'abonner navigation icon
FR
navigation icon menu icon S'abonner
navigation icon Accueil navigation icon Catalogue
icon language Langues navigation icon Menu
icon close
icon arrow

Rechercher

icon searchbar

Rechercher

Catalogue

icon close
icon close
icon close
icon language

Langues

icon close
background image
button download
icon share social
Category HAL Allergy Completes Patient Enrollment for its Phase II Trial With SUBLIVAC® FIX Phleum Pratense
Lire
Lire

HAL Allergy Completes Patient Enrollment for its Phase II Trial With SUBLIVAC® FIX Phleum Pratense

  • 1

    page

  • English

  • Documents

Publié par
icon arrow

  • 1

    page

  • English

  • Documents

Lire
Lire
icon

Description

HAL Allergy Completes Patient Enrollment for its Phase II Trial With SUBLIVAC® FIX Phleum Pratense PR Newswire LEIDEN - The Netherlands, December 19, 2012 LEIDEN - The Netherlands, December 19, 2012 /PRNewswire/ -- HAL Allergy B.V.
Voir icon arrow
icon success

Ajouté à mes notifications

Vous serez informé des prochaines publications.